Fortress Biotech, Inc.FBIONASDAQ
Loading
Revenue PerformanceStable
Percentile Rank73
3Y CAGR-6.3%
5Y CAGR+6.4%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-6.3%/yr
vs +29.6%/yr prior
5Y CAGR
+6.4%/yr
Recent deceleration
Acceleration
-35.9pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$62.30M+8.0%
2024$57.67M-31.8%
2023$84.51M+11.6%
2022$75.74M+10.1%
2021$68.79M+50.9%
2020$45.60M+24.5%
2019$36.63M+36.3%
2018$26.88M-85.7%
2017$187.58M+1038.3%
2016$16.48M-